After record fundraising, biotechs return to earth – Media24

Biotech companies, which have experienced intense enthusiasm for supporting the pandemic, now face a shortage of funds: a situation that could whet the appetites of the big labs that covet them. When BioNTech in Germany and Moderna in the US made headlines at the end of 2020 with their first vaccines against Covid-19, these young …

After record fundraising, biotechs return to earth – Media24 Read More »